SPERATUM

Speratum is a pre-clinical stage biotechnology company focused on research and development of targeted molecular therapeutics based on core technologies exclusively licensed from Baylor College of Medicine. Speratum's platforms for drug delivery and oligonucleotide administration have broad application potential, and have been out-licensed for multiple therapeutic and research modalities... Speratum is currently in advance pre-clinical stages of development for its lead therapeutic candidate, a small RNA tumor suppressor in several solid cancer... Speratum Biopharma, Inc. is an innovative biotechnology company focused on pre-clinical research and development of oligonucleotide therapeutics for the treatment of cancer. The company's primary focus is developing a multi-component therapeutic against multiple cancer types that includes a proprietary RNA interference (RNAi)-inducing mimic of miR-198, a naturally occurring microRNA involved in the pathogenesis of several solid cancers,..

Also known as: Speratum Biopharma, Speratum Biopharma, Inc